• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Jan 5;18(1):e13248.
doi: 10.1111/irv.13248. eCollection 2024 Jan. Surveillance of seasonal influenza viruses during the COVID-19 pandemic in Tokyo, Japan, 2018-2023, a single-center study

Hidenori Takahashi[SUP] 1 2 3 [/SUP], Hiroki Nagamatsu[SUP] 1 [/SUP], Yuka Yamada[SUP] 1 [/SUP], Naoya Toba[SUP] 1 [/SUP], Mio Toyama-Kousaka[SUP] 1 [/SUP], Shinichiro Ota[SUP] 1 [/SUP], Miwa Morikawa[SUP] 1 [/SUP], Masahiro Shinoda[SUP] 1 [/SUP], Syunsuke Takano[SUP] 2 [/SUP], Suzuko Fukasawa[SUP] 2 [/SUP], Kaeyoung Park[SUP] 2 [/SUP], Takahiko Yano[SUP] 2 [/SUP], Masamichi Mineshita[SUP] 3 [/SUP], Masaharu Shinkai[SUP] 1 [/SUP]



Affiliations
Free PMC article Abstract

Introduction: COVID-19 pandemic led to significant reductions in influenza detection worldwide, fueling debates on whether influenza truly ceased circulating in communities. The number of influenza cases decreased significantly in Japan, raising concerns about the potential risk of decreased immunity to influenza in the population. Our single-center study aimed to investigate influenza trends before and during the COVID-19 pandemic in Tokyo, Japan.
Materials and methods: This cross-sectional study included patients of all ages who visited Tokyo Shinagawa Hospital between April 1, 2018, and March 31, 2023. Influenza and COVID-19 tests were conducted using Quick Navi-Flu2 and polymerase chain reaction (PCR). We analyzed data from before and during the COVID-19 epidemic, based on patient background, hospitalization, and deaths, collected from medical records.
Results: A total of 12 577 influenza tests were conducted, with approximately 100 tests consistently performed each month even in the influenza off-season. Throughout the observation period, 962 positive cases were identified. However, no cases were observed for 27 months between March 2020 and November 2022. Influenza A cases were reobserved in December 2022, followed by influenza B cases in March 2023, similar to the influenza incidence reports from Tokyo. The positivity rate during the 2022-2023 winter season was lower than before the COVID-19 epidemic and decreased in elderly patients, with no hospitalizations or deaths observed.
Conclusion: This single-center study provided actual trend data for influenza patients before and during COVID-19 outbreaks in Tokyo, which could offer insights into the potential impact and likelihood of influenza virus infection in Japan.

Keywords: COVID‐19 pandemic; Quick Navi‐Flu2; immunity; influenza trends; population health.

 
Back
Top Bottom